Quick Links

Contact Us

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diab

Authors: Robert A Kloner|||Joel Neutel|||Eli M Roth|||Robert Weiss|||Myron H Weinberger|||Kamlesh M Thakker|||Brian Schwartz|||Harry Shi|||Anne-Marie Gregg|||

Journal: The Annals of pharmacotherapy

Publication Type: Journal Article

Date: 2008

DOI: 10.1345/aph.1L076

ID: 18827176

Affiliations:

Affiliations

    Heart Institute, Good Samaritan Hospital; Professor of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90017, USA. rkloner@goodsam.org|||||||||||||||||||||||||||

Abstract

Attainment of blood pressure (BP) goals in patients with diabetes is critical both to reduce the risk of cardiovascular events and to delay the progression of renal disease. While therapeutic guidelines advise initial therapy with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, monotherapy with these agents may not be sufficient to attain target BP.

Chemical List

    Antihypertensive Agents|||Tetrahydroisoquinolines|||Amlodipine|||Losartan|||Quinapril